Quiz Summary
0 of 5 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 5 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 5
1. Question
The “2013 ACCF/AHA Guideline” outlines specific recommendations for anticoagulant therapy in conjunction with primary PCI. Which anticoagulant is NOT recommended for routine use in STEMI patients undergoing primary PCI?
CorrectIncorrect -
Question 2 of 5
2. Question
Based on the “2013 ACCF/AHA Guideline,” what is the recommended approach for risk stratification in patients with STEMI?
CorrectIncorrect -
Question 3 of 5
3. Question
In the PLATO trial, which compared Ticagrelor with Clopidogrel for acute coronary syndromes, what was the primary efficacy endpoint?
CorrectIncorrect -
Question 4 of 5
4. Question
According to the PLATO trial, how did the rates of overall major bleeding in patients treated with Ticagrelor compare to those treated with Clopidogrel?
CorrectIncorrect -
Question 5 of 5
5. Question
What was the conclusion of the PLATO trial regarding the efficacy of Ticagrelor versus Clopidogrel in patients with acute coronary syndromes?
CorrectIncorrect
